atezolizumab和贝伐单抗联合治疗不可切除肝细胞癌引起的免疫性血小板减少性紫癜1例

{"title":"atezolizumab和贝伐单抗联合治疗不可切除肝细胞癌引起的免疫性血小板减少性紫癜1例","authors":"A. Kuwano, Kosuke Tanaka, Shigehiro Nagasawa, Yusuke Morita, M. Yada, A. Masumoto, K. Motomura","doi":"10.2957/kanzo.63.335","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Immune thrombocytopenic purpura caused by combination therapy of atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: A case presentation\",\"authors\":\"A. Kuwano, Kosuke Tanaka, Shigehiro Nagasawa, Yusuke Morita, M. Yada, A. Masumoto, K. Motomura\",\"doi\":\"10.2957/kanzo.63.335\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":35810,\"journal\":{\"name\":\"Acta Hepatologica Japonica\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Hepatologica Japonica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2957/kanzo.63.335\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Hepatologica Japonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2957/kanzo.63.335","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}